Medical News / Mark G. Lebwohl, MD: Winter Clinical Presentation on Choosing the Right Psoriasis Drug

In a recent interview with HCPLive, Mark G. Lebwohl, MD, from the Icahn School of Medicine at Mount Sinai in New York, discussed his 2023 Winter Clinical Miami presentation titled ‘Psoriasis: Which Drug for Which Patient?’ Lebwohl first began with a discussion of his background as Dean of Clinical Therapeutics at the Icahn School of Medicine, as a dermatologist, and his research in the psoriasis space. “I have been Chairman of Dermatology here for about a quarter of a century before a year and a half ago becoming Dean for Clinical Therapeutics,” he explained. “And I also am very involved in clinical research for virtually every psoriasis product that comes to market.” Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

MORE MEDICAL NEWS
Henry Lim, MD, spoke with HCPLive about major takeaways from his presentation at the American Academy ... read more
An oral tyrosine kinase 2 (TYK2) inhibitor, called NDI-034858, led to substantial skin clearance improvement for ... read more
New late-breaking data presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting in New ... read more
Late-breaking data presented at the the American Academy of Dermatology (AAD) 2023 Annual Meeting in New ... read more